Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Leventhal

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Dermatology|April 30, 2013
Crystal deodorant-induced axillary granulomatous dermatitisJonathan S Leventhal, Joshua A Farhadian, Kristen E Miller, et al.
International Journal of Dermatology|June 9, 2026
Clinicopathological Challenge: A Rapidly Progressive Bullous Ulcer in a Patient Receiving GilteritinibLenique K Huggins, Rachel G Collins, Matthew H Friedland, et al.
Journal of the American Academy of Dermatology|August 27, 2019
Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapyLihi Atzmony, Young H Lim, Claire Hamilton, et al.
Blood Reviews|July 23, 2017
The skin as a window to the blood: Cutaneous manifestations of myeloid malignanciesAlvin W Li, Emily S Yin, Maximilian Stahl, et al.
Pediatric Dermatology|January 30, 2016
Recurrent Coxsackievirus Infection in a Patient with Lamellar IchthyosisWilliam E Damsky, Jonathan S Leventhal, David Khalil, et al.
JAMA Dermatology|July 14, 2016
Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 ImmunotherapyVeronica J Shi, Nemanja Rodic, Scott Gettinger, et al.
Journal of Drugs in Dermatology : JDD|November 9, 2023
INDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse EventsAlana Deutsch, Mario Lacouture, Anneke Andriessen, et al.
JAAD International|May 30, 2023
Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerabilityAnnika Belzer, Jolanta Pach, Ryland D Mortlock, et al.
Breast Cancer Research and Treatment|January 15, 2024
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitorsAlexander S Bang, Christopher J Fay, Nicole R LeBoeuf, et al.
JAMA Dermatology|April 4, 2019
Second-Hit, Postzygotic PMVK and MVD Mutations in Linear PorokeratosisLihi Atzmony, Habib M Khan, Young H Lim, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Dermatology|April 30, 2013
Crystal deodorant-induced axillary granulomatous dermatitisJonathan S Leventhal, Joshua A Farhadian, Kristen E Miller, et al.
International Journal of Dermatology|June 9, 2026
Clinicopathological Challenge: A Rapidly Progressive Bullous Ulcer in a Patient Receiving GilteritinibLenique K Huggins, Rachel G Collins, Matthew H Friedland, et al.
Journal of the American Academy of Dermatology|August 27, 2019
Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapyLihi Atzmony, Young H Lim, Claire Hamilton, et al.
Blood Reviews|July 23, 2017
The skin as a window to the blood: Cutaneous manifestations of myeloid malignanciesAlvin W Li, Emily S Yin, Maximilian Stahl, et al.
Pediatric Dermatology|January 30, 2016
Recurrent Coxsackievirus Infection in a Patient with Lamellar IchthyosisWilliam E Damsky, Jonathan S Leventhal, David Khalil, et al.
JAMA Dermatology|July 14, 2016
Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 ImmunotherapyVeronica J Shi, Nemanja Rodic, Scott Gettinger, et al.
Journal of Drugs in Dermatology : JDD|November 9, 2023
INDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse EventsAlana Deutsch, Mario Lacouture, Anneke Andriessen, et al.
JAAD International|May 30, 2023
Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerabilityAnnika Belzer, Jolanta Pach, Ryland D Mortlock, et al.
Breast Cancer Research and Treatment|January 15, 2024
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitorsAlexander S Bang, Christopher J Fay, Nicole R LeBoeuf, et al.
JAMA Dermatology|April 4, 2019
Second-Hit, Postzygotic PMVK and MVD Mutations in Linear PorokeratosisLihi Atzmony, Habib M Khan, Young H Lim, et al.
Pageof 8